Office of Science and Technology Policy:

Violation of the Antideficiency Act

GAO-12-200T: Published: Nov 2, 2011. Publicly Released: Nov 2, 2011.

Additional Materials:

Contact:

Thomas H. Armstrong
(202) 512-8257
contact@gao.gov

 

Office of Public Affairs
(202) 512-4800
youngc1@gao.gov

This testimony discusses our October 11 opinion concerning the Office of Science and Technology Policy's (OSTP) use of appropriations for bilateral activities with the government of the People's Republic of China.

In the opinion, we determined that OSTP violated a statutory provision prohibiting the agency from using its appropriations for bilateral engagements with China or any Chinese-owned company. Because no funds were available for such purpose, OSTP's actions also violated the Antideficiency Act, a fiscal statute central to Congress's constitutional power of the purse.

Oct 13, 2020

Oct 7, 2020

Sep 30, 2020

Sep 9, 2020

Aug 25, 2020

Aug 6, 2020

Jun 17, 2020

Jun 10, 2020

Jun 8, 2020

Looking for more? Browse all our products here